Principal Investigator Remi Creusot to Present Three Posters at IDS Congress 2018

CCTI Principal Investigator, Dr. Remi Creusot, has an astounding three abstracts chosen for poster presentation at the annual congress of the Immunology of Diabetes Society, being held this year in London, England.

Dr. Creusot is an assistant professor in the Department of Medicine and principal investigator at the Columbia Center for Translational Immunology and the Naomi Berrie Diabetes Center at Columbia University Medical Center and his research interests revolve around the pathogenesis and prevention of Type 1 Diabetes. 

For the  IDS Congress, Dr. Creusot will present three posters in Poster Session A, 18:00-19:00 on 10/25/2018.

  • Phenotypic and transcriptional analysis of stromal and dendritic cells in pancreatic lymph nodes in Type 1 diabetes

  • Tolerogenic multi-epitope DNA vaccination in autoimmune diabetes

  • and Nanoparticle- and dendritic cell-mediated in vivo delivery of multiple epitopes-encoding mRNA for antigen-specific immunotherapy of T1D

For a complete listing of events and speakers, please see the IDS 2018 webpage here.